(-0.22%) 5 011.12 points
(0.06%) 37 775 points
(-0.52%) 15 601 points
(3.86%) $85.92
(1.20%) $1.778
(0.70%) $2 414.70
(0.72%) $28.59
(-0.13%) $953.30
(0.27%) $0.942
(0.26%) $11.07
(0.35%) $0.807
(0.05%) $93.95
5 days till quarter result
(bmo 2024-04-24)
Expected move: +/- 10.20%
@ $12.36
Issued: 14 Feb 2024 @ 09:30
Return: -7.36%
Previous signal: Feb 12 - 15:00
Previous signal:
Return: -1.98 %
Live Chart Being Loaded With Signals
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation...
Stats | |
---|---|
Today's Volume | 172 739 |
Average Volume | 220 370 |
Market Cap | 368.35M |
EPS | $0.210 ( 2024-02-29 ) |
Next earnings date | ( $0.170 ) 2024-04-24 |
Last Dividend | $0.100 ( 2022-01-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | 42.41 |
ATR14 | $0.0120 (0.10%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-25 | Moorhead Daniel J | Sell | 6 084 | Common Stock |
2024-03-25 | Lucsok Anna | Sell | 7 672 | Common Stock |
2024-03-25 | Sandgaard Thomas | Sell | 2 268 | Common Stock |
2024-03-05 | Moorhead Daniel J | Buy | 5 000 | Common Stock (Restricted Stock Award) |
2024-01-27 | Lucsok Anna | Buy | 5 000 | Common Stock (Restricted Stock Award) |
INSIDER POWER |
---|
-38.34 |
Last 100 transactions |
Buy: 368 705 | Sell: 936 982 |
Volume Correlation
Zynex Inc Correlation
10 Most Positive Correlations | |
---|---|
MMAC | 0.896 |
BOCH | 0.863 |
BMRN | 0.848 |
CTRN | 0.841 |
STRO | 0.838 |
XEL | 0.832 |
CAAS | 0.826 |
ISRG | 0.821 |
AMRB | 0.814 |
GLSI | 0.812 |
10 Most Negative Correlations | |
---|---|
APOP | -0.971 |
RMRM | -0.939 |
MAGS | -0.936 |
TDAC | -0.897 |
CMLF | -0.868 |
SVOK | -0.836 |
EMBCV | -0.824 |
TLGT | -0.823 |
SPRT | -0.82 |
TALS | -0.82 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Zynex Inc Correlation - Currency/Commodity
Zynex Inc Financials
Annual | 2023 |
Revenue: | $184.32M |
Gross Profit: | $145.96M (79.19 %) |
EPS: | $0.270 |
Q4 | 2023 |
Revenue: | $47.28M |
Gross Profit: | $37.01M (78.28 %) |
EPS: | $0.0362 |
Q3 | 2023 |
Revenue: | $49.92M |
Gross Profit: | $40.36M (80.86 %) |
EPS: | $0.100 |
Q2 | 2023 |
Revenue: | $44.95M |
Gross Profit: | $35.68M (79.37 %) |
EPS: | $0.0921 |
Financial Reports:
No articles found.
Zynex Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.136 | 2014-06-17 |
Last Dividend | $0.100 | 2022-01-05 |
Next Dividend | $0 | N/A |
Payout Date | 2022-01-21 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.300 | -- |
Avg. Dividend % Per Year | 0.21% | -- |
Score | 2.83 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.57 | |
Div. Directional Score | 8.39 | -- |
Year | Amount | Yield |
---|---|---|
2014 | $0.136 | 42.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0.0636 | 2.14% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0.100 | 1.07% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0528 | 1.500 | 8.94 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0690 | 1.200 | 7.70 | 9.24 | [0 - 0.3] |
returnOnEquityTTM | 0.168 | 1.500 | 9.24 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.000411 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 4.74 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.85 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.41 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.436 | -1.500 | 2.73 | -4.10 | [0 - 0.6] |
interestCoverageTTM | 11.13 | 1.000 | 6.99 | 6.99 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.531 | 2.00 | 9.82 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.495 | 2.00 | 9.75 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.334 | -1.500 | 4.66 | -7.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.792 | 1.000 | 0.136 | 0.136 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0661 | 1.000 | -0.678 | -0.678 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.290 | 1.000 | 9.50 | 9.50 | [0.2 - 2] |
assetTurnoverTTM | 1.307 | 0.800 | 4.62 | 3.70 | [0.5 - 2] |
Total Score | 11.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 42.46 | 1.000 | 5.81 | 0 | [1 - 100] |
returnOnEquityTTM | 0.168 | 2.50 | 9.51 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.495 | 2.00 | 9.84 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.531 | 2.00 | 9.82 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.000411 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 0.801 | 1.500 | 7.99 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0967 | 1.000 | -0.0814 | 0 | [0.1 - 0.5] |
Total Score | 5.57 |
Zynex Inc
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators